Dallah Healthcare Co. reported a net profit of SAR 85 million for Q1 2017, up 46.3 percent year-on-year, thanks to higher revenues, a decrease in some provisions, and lower selling and distribution expenses.
On a sequential basis, Q1 net profit jumped 63.46 percent, on the back of lower expenses.
Item | Q1 2016 | Q1 2017 | Change |
---|---|---|---|
Revenues | 285.03 | 302.75 | 6.2 % |
Gross Income | 132.53 | 143.60 | 8.4 % |
Operating Income | 61.90 | 85.82 | 38.6 % |
Net Income | 58.07 | 85.05 | 46.5 % |
Average Shares | 90.00 | 90.00 | - |
EPS (Riyals) | 0.65 | 0.94 | 46.5 % |
Item | Q4 2016 | Q1 2017 | Change |
---|---|---|---|
Revenues | 316.24 | 302.75 | (4.3 %) |
Gross Income | 151.01 | 143.60 | (4.9 %) |
Operating Income | 57.96 | 85.82 | 48.1 % |
Net Income | 51.71 | 85.05 | 64.5 % |
Average Shares | 90.00 | 90.00 | - |
EPS (Riyals) | 0.57 | 0.94 | 64.5 % |
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
Q1 2008 | - | - | - | - | - | - | - |
Q2 2008 | - | - | - | - | - | - | - |
Q3 2008 | - | - | - | - | - | - | - |
Q4 2008 | - | - | - | - | - | - | - |
2008 | - | - | - | - | - | - | - |
Q1 2009 | - | - | - | - | - | - | - |
Q2 2009 | - | - | - | - | - | - | - |
Q3 2009 | - | - | - | - | - | - | - |
Q4 2009 | - | - | - | - | - | - | - |
2009 | 513.86 | - | 155.79 | - | 66.04 | - | 0.73 |
Q1 2010 | - | - | - | - | - | - | - |
Q2 2010 | - | - | - | - | - | - | - |
Q3 2010 | 104.78 | - | 36.90 | - | 17.82 | - | 0.20 |
Q4 2010 | 120.09 | - | 39.97 | - | 24.33 | - | 0.27 |
2010 | 472.52 | (8.0 %) | 169.83 | 9.0 % | 94.47 | 43.0 % | 1.05 |
Q1 2011 | 129.97 | - | 49.69 | - | 35.25 | - | 0.39 |
Q2 2011 | 139.34 | - | 50.86 | - | 27.14 | - | 0.30 |
Q3 2011 | 115.44 | 10.2 % | 37.37 | 1.3 % | 15.49 | (13.1 %) | 0.17 |
Q4 2011 | 142.59 | 18.7 % | 51.97 | 30.0 % | 35.53 | 46.0 % | 0.39 |
2011 | 527.34 | 11.6 % | 189.89 | 11.8 % | 113.40 | 20.0 % | 1.26 |
Q1 2012 | 154.04 | 18.5 % | 72.82 | 46.5 % | 37.96 | 7.7 % | 0.42 |
Q2 2012 | 161.32 | 15.8 % | 73.73 | 45.0 % | 37.09 | 36.7 % | 0.41 |
Q3 2012 | 142.26 | 23.2 % | 59.00 | 57.9 % | 23.94 | 54.5 % | 0.27 |
Q4 2012 | 179.43 | 25.8 % | 81.51 | 56.9 % | 34.37 | (3.3 %) | 0.38 |
2012 | 636.86 | 20.8 % | 286.87 | 51.1 % | 133.36 | 17.6 % | 1.48 |
Q1 2013 | 183.73 | 19.3 % | 84.40 | 15.9 % | 39.04 | 2.8 % | 0.43 |
Q2 2013 | 187.79 | 16.4 % | 80.68 | 9.4 % | 23.64 | (36.3 %) | 0.26 |
Q3 2013 | 167.08 | 17.4 % | 66.67 | 13.0 % | 21.84 | (8.7 %) | 0.24 |
Q4 2013 | 211.05 | 17.6 % | 95.71 | 17.4 % | 52.11 | 51.6 % | 0.58 |
2013 | 749.65 | 17.7 % | 327.45 | 14.1 % | 136.63 | 2.5 % | 1.52 |
Q1 2014 | 207.57 | 13.0 % | 87.60 | 3.8 % | 40.50 | 3.7 % | 0.45 |
Q2 2014 | 219.45 | 16.9 % | 93.78 | 16.2 % | 34.33 | 45.2 % | 0.38 |
Q3 2014 | 192.79 | 15.4 % | 75.36 | 13.0 % | 21.94 | 0.5 % | 0.24 |
Q4 2014 | 240.08 | 13.8 % | 103.54 | 8.2 % | 50.35 | (3.4 %) | 0.56 |
2014 | 858.75 | 14.6 % | 358.57 | 9.5 % | 147.12 | 7.7 % | 1.63 |
Q1 2015 | 240.40 | 15.8 % | 102.13 | 16.6 % | 47.82 | 18.1 % | 0.53 |
Q2 2015 | 245.23 | 11.7 % | 100.89 | 7.6 % | 35.86 | 4.4 % | 0.40 |
Q3 2015 | 223.93 | 16.2 % | 87.92 | 16.7 % | 26.78 | 22.1 % | 0.30 |
Q4 2015 | 276.50 | 15.2 % | 116.81 | 12.8 % | 54.60 | 8.4 % | 0.61 |
2015 | 985.44 | 14.8 % | 407.14 | 13.5 % | 165.06 | 12.2 % | 1.83 |
Q1 2016 | 285.03 | 18.6 % | 132.53 | 29.8 % | 58.07 | 21.4 % | 0.65 |
Q2 2016 | 288.35 | 17.6 % | 129.78 | 28.6 % | 54.14 | 51.0 % | 0.60 |
Q3 2016 | 273.17 | 22.0 % | 122.38 | 39.2 % | 60.80 | 127.0 % | 0.68 |
Q4 2016 | 316.24 | 14.4 % | 151.01 | 29.3 % | 51.71 | (5.3 %) | 0.57 |
2016 | 1,162.79 | 18.0 % | 535.70 | 31.6 % | 224.71 | 36.1 % | 2.50 |
Q1 2017 | 302.75 | 6.2 % | 143.60 | 8.4 % | 85.05 | 46.5 % | 0.94 |
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
2007 | - | - | - | - | - | - | - |
2008 | - | - | - | - | - | - | - |
2009 | 513.86 | - | 155.79 | - | 66.04 | - | 0.73 |
2010 | 472.52 | (8.0 %) | 169.83 | 9.0 % | 94.47 | 43.0 % | 1.05 |
2011 | 527.34 | 11.6 % | 189.89 | 11.8 % | 113.40 | 20.0 % | 1.26 |
2012 | 636.86 | 20.8 % | 286.87 | 51.1 % | 133.36 | 17.6 % | 1.48 |
2013 | 749.65 | 17.7 % | 327.45 | 14.1 % | 136.63 | 2.5 % | 1.52 |
2014 | 858.75 | 14.6 % | 358.57 | 9.5 % | 147.12 | 7.7 % | 1.63 |
2015 | 985.44 | 14.8 % | 407.14 | 13.5 % | 165.06 | 12.2 % | 1.83 |
2016 | 1,162.79 | 18.0 % | 535.70 | 31.6 % | 224.71 | 36.1 % | 2.50 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
2008 | - | - | - |
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | - | - | - |
Q4 2009 | - | - | - |
2009 | 30.32 % | 18.58 % | 13.44 % |
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | - | - | - |
Q4 2010 | - | - | - |
2010 | 35.94 % | 22.73 % | 19.99 % |
Q1 2011 | - | - | - |
Q2 2011 | 35.90 % | 22.84 % | 21.15 % |
Q3 2011 | 35.24 % | 22.42 % | 20.24 % |
Q4 2011 | 36.01 % | 24.05 % | 22.15 % |
2011 | 36.01 % | 24.05 % | 22.15 % |
Q1 2012 | 38.63 % | 24.79 % | 21.67 % |
Q2 2012 | 41.14 % | 25.88 % | 22.58 % |
Q3 2012 | 42.90 % | 25.84 % | 22.97 % |
Q4 2012 | 45.06 % | 25.05 % | 20.93 % |
2012 | 45.04 % | 25.06 % | 20.94 % |
Q1 2013 | 44.79 % | 24.18 % | 20.16 % |
Q2 2013 | 44.08 % | 22.36 % | 17.45 % |
Q3 2013 | 43.63 % | 21.80 % | 16.56 % |
Q4 2013 | 43.68 % | 23.30 % | 18.23 % |
2013 | 43.68 % | 23.16 % | 18.23 % |
Q1 2014 | 42.75 % | 23.14 % | 17.85 % |
Q2 2014 | 42.69 % | 22.94 % | 18.48 % |
Q3 2014 | 42.42 % | 22.43 % | 17.92 % |
Q4 2014 | 41.90 % | 22.11 % | 17.11 % |
2014 | 41.76 % | 22.14 % | 17.13 % |
Q1 2015 | 41.98 % | 21.38 % | 15.76 % |
Q2 2015 | 41.58 % | 21.72 % | 15.48 % |
Q3 2015 | 41.54 % | 21.77 % | 15.49 % |
Q4 2015 | 41.35 % | 21.81 % | 15.34 % |
2015 | 41.32 % | 22.03 % | 15.35 % |
Q1 2016 | 42.51 % | 23.29 % | 17.20 % |
Q2 2016 | 43.49 % | 24.24 % | 18.50 % |
Q3 2016 | 44.66 % | 25.57 % | 19.88 % |
Q4 2016 | 46.07 % | 24.94 % | 19.47 % |
2016 | 46.07 % | 24.94 % | 19.47 % |
Q1 2017 | 46.32 % | 26.38 % | 21.29 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2007 | - | - | - |
2008 | - | - | - |
2009 | 30.32 % | 18.58 % | 13.44 % |
2010 | 35.94 % | 22.73 % | 19.99 % |
2011 | 36.01 % | 24.05 % | 22.15 % |
2012 | 45.04 % | 25.06 % | 20.94 % |
2013 | 43.68 % | 23.16 % | 18.23 % |
2014 | 41.76 % | 22.14 % | 17.13 % |
2015 | 41.32 % | 22.03 % | 15.35 % |
2016 | 46.07 % | 24.94 % | 19.47 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | - | - | - |
Q4 2009 | - | - | - |
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | 35.22 % | 21.56 % | 17.00 % |
Q4 2010 | 33.28 % | 18.14 % | 20.26 % |
Q1 2011 | 38.23 % | 26.96 % | 27.12 % |
Q2 2011 | 36.50 % | 24.01 % | 19.47 % |
Q3 2011 | 32.37 % | 19.85 % | 13.42 % |
Q4 2011 | 36.44 % | 24.82 % | 27.29 % |
Q1 2012 | 47.27 % | 29.16 % | 24.64 % |
Q2 2012 | 45.71 % | 28.00 % | 22.99 % |
Q3 2012 | 41.48 % | 20.83 % | 16.83 % |
Q4 2012 | 45.43 % | 22.23 % | 19.16 % |
Q1 2013 | 45.94 % | 25.32 % | 21.25 % |
Q2 2013 | 42.96 % | 20.75 % | 12.59 % |
Q3 2013 | 39.90 % | 18.63 % | 13.07 % |
Q4 2013 | 45.35 % | 27.52 % | 24.69 % |
Q1 2014 | 42.20 % | 24.47 % | 19.51 % |
Q2 2014 | 42.73 % | 20.38 % | 15.64 % |
Q3 2014 | 39.09 % | 16.97 % | 11.38 % |
Q4 2014 | 43.13 % | 25.78 % | 20.97 % |
Q1 2015 | 42.48 % | 21.43 % | 14.17 % |
Q2 2015 | 41.14 % | 21.75 % | 14.62 % |
Q3 2015 | 39.26 % | 17.88 % | 11.96 % |
Q4 2015 | 42.25 % | 25.38 % | 19.75 % |
Q1 2016 | 46.50 % | 26.86 % | 21.08 % |
Q2 2016 | 45.01 % | 25.49 % | 19.84 % |
Q3 2016 | 44.80 % | 24.50 % | 18.81 % |
Q4 2016 | 47.75 % | 23.08 % | 18.25 % |
Q1 2017 | 47.43 % | 32.36 % | 28.09 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2008 | - | - | - | - |
Q2 2008 | - | - | - | - |
Q3 2008 | - | - | - | - |
Q4 2008 | - | - | - | - |
Q1 2009 | - | - | - | - |
Q2 2009 | - | - | - | - |
Q3 2009 | - | - | - | - |
Q4 2009 | - | - | - | - |
Q1 2010 | - | - | - | - |
Q2 2010 | - | - | - | - |
Q3 2010 | 90.00 | - | - | 3.67 |
Q4 2010 | 90.00 | - | - | 3.94 |
Q1 2011 | 90.00 | - | - | 4.29 |
Q2 2011 | 90.00 | 1.16 | 1.16 | 4.63 |
Q3 2011 | 90.00 | 1.14 | 1.14 | 4.80 |
Q4 2011 | 90.00 | 1.26 | 1.30 | 5.21 |
Q1 2012 | 90.00 | 1.29 | 1.33 | 5.66 |
Q2 2012 | 90.00 | 1.40 | 1.44 | 6.04 |
Q3 2012 | 90.00 | 1.49 | 1.53 | 6.31 |
Q4 2012 | 90.00 | 1.48 | 1.48 | 12.40 |
Q1 2013 | 90.00 | 1.49 | 1.49 | 12.83 |
Q2 2013 | 90.00 | 1.34 | 1.34 | 12.37 |
Q3 2013 | 90.00 | 1.32 | 1.32 | 12.64 |
Q4 2013 | 90.00 | 1.52 | 1.52 | 13.22 |
Q1 2014 | 90.00 | 1.53 | 1.53 | 13.75 |
Q2 2014 | 90.00 | 1.65 | 1.65 | 13.36 |
Q3 2014 | 90.00 | 1.65 | 1.65 | 13.65 |
Q4 2014 | 90.00 | 1.63 | 1.63 | 14.15 |
Q1 2015 | 90.00 | 1.72 | 1.56 | 14.74 |
Q2 2015 | 90.00 | 1.73 | 1.58 | 14.63 |
Q3 2015 | 90.00 | 1.79 | 1.63 | 14.86 |
Q4 2015 | 90.00 | 1.83 | 1.68 | 15.48 |
Q1 2016 | 90.00 | 1.95 | 1.97 | 16.15 |
Q2 2016 | 90.00 | 2.15 | 2.21 | 15.76 |
Q3 2016 | 90.00 | 2.53 | 2.48 | 16.26 |
Q4 2016 | 90.00 | 2.50 | 2.52 | 16.85 |
Q1 2017 | 90.00 | 2.80 | 2.79 | 17.78 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2007 | - | - | - | - |
2008 | - | - | - | - |
2009 | 90.00 | 0.73 | 0.77 | 3.34 |
2010 | 90.00 | 1.05 | 1.05 | 3.94 |
2011 | 90.00 | 1.26 | 1.30 | 5.21 |
2012 | 90.00 | 1.48 | 1.48 | 12.40 |
2013 | 90.00 | 1.52 | 1.52 | 13.22 |
2014 | 90.00 | 1.63 | 1.63 | 14.15 |
2015 | 90.00 | 1.83 | 1.68 | 15.48 |
2016 | 90.00 | 2.50 | 2.52 | 16.85 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | - | - | - |
Q4 2009 | - | - | - |
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | - | - | - |
Q4 2010 | - | - | - |
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | 25.26 | 25.26 | 3.02 |
Q1 2013 | 23.15 | 23.15 | 2.70 |
Q2 2013 | 26.26 | 26.26 | 2.85 |
Q3 2013 | 26.93 | 26.93 | 2.82 |
Q4 2013 | 26.15 | 26.15 | 3.00 |
Q1 2014 | 33.02 | 33.02 | 3.69 |
Q2 2014 | 33.91 | 33.91 | 4.19 |
Q3 2014 | 43.67 | 43.67 | 5.29 |
Q4 2014 | 45.25 | 45.25 | 5.23 |
Q1 2015 | 40.15 | 44.08 | 4.67 |
Q2 2015 | 45.84 | More than 50 | 5.43 |
Q3 2015 | 32.29 | 35.31 | 3.88 |
Q4 2015 | 27.26 | 29.73 | 3.23 |
Q1 2016 | 27.46 | 27.14 | 3.31 |
Q2 2016 | 28.54 | 27.81 | 3.89 |
Q3 2016 | 21.29 | 21.71 | 3.31 |
Q4 2016 | 27.05 | 26.85 | 4.01 |
Q1 2017 | 25.95 | 25.99 | 4.08 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2007 | - | - | - |
2008 | - | - | - |
2009 | - | - | - |
2010 | - | - | - |
2011 | - | - | - |
2012 | 25.26 | 25.26 | 3.02 |
2013 | 26.15 | 26.15 | 3.00 |
2014 | 45.25 | 45.25 | 5.23 |
2015 | 27.26 | 29.73 | 3.23 |
2016 | 27.05 | 26.85 | 4.01 |
Q1 2017
2017
Period | Medical Services | Medicine and Pharmaceutical Products |
---|---|---|
Q1 2011 | 118.62 | 11.35 |
Q2 2011 | 132.76 | 6.58 |
Q3 2011 | 110.16 | 5.99 |
Q4 2011 | 134.16 | 7.73 |
Q1 2012 | 141.87 | 12.17 |
Q2 2012 | 148.75 | 12.57 |
Q3 2012 | 133.35 | 8.91 |
Q4 2012 | 163.03 | 16.20 |
Q1 2013 | 169.97 | 13.76 |
Q2 2013 | 168.24 | 19.56 |
Q3 2013 | 158.17 | 8.92 |
Q4 2013 | 192.80 | 18.25 |
Q1 2014 | 195.44 | 12.12 |
Q2 2014 | 201.76 | 17.69 |
Q3 2014 | 177.26 | 15.52 |
Q4 2014 | 223.92 | 15.02 |
Q1 2015 | 224.02 | 16.38 |
Q2 2015 | 228.38 | 16.85 |
Q3 2015 | 215.41 | 8.52 |
Q4 2015 | 257.40 | 18.49 |
Q1 2016 | 276.15 | 8.88 |
Q2 2016 | 277.42 | 10.93 |
Q3 2016 | 265.04 | 8.13 |
Q4 2016 | 111.39 | 8.73 |
Q1 2017 | 239.94 | 62.81 |
Period | Medical Services | Medicine and Pharmaceutical Products |
---|---|---|
2010 | 445.44 | 27.08 |
2011 | 495.70 | 31.64 |
2012 | 587.00 | 49.85 |
2013 | 689.17 | 60.48 |
2014 | 798.39 | 60.35 |
2015 | 925.20 | 60.24 |
2016 | 930.00 | 36.67 |
Item | Q1 2017 (e) | Q1 2017 (a) | Change |
---|---|---|---|
Average | 62.97 | 85.05 | 35.07 % |
Item | Q1 2017 (e) | Q1 2017 (a) | Change |
---|---|---|---|
Albilad Capital | 66.00 | 85.05 | 28.9 % |
Al Rajhi Capital | 64.00 | 85.05 | 32.9 % |
OSOOL AND BAKHEET | 63.00 | 85.05 | 35.0 % |
Arbah Capital | 63.00 | 85.05 | 35.0 % |
Sico | 62.00 | 85.05 | 37.2 % |
AlJazira Capital | 59.80 | 85.05 | 42.2 % |
Current | |
Market Cap (M Riyal) | 16,449.31 |
Enterprise Value (EV) (M) | 18,352.79 |
Shares Outstanding ((M)) | 97.68 |
EPS ( Riyal) (TTM) | 3.94 |
Book Value (BV) ( Riyal) | 34.02 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 42.74 |
P/E (TTM) | 42.74 |
Price/book | 4.95 |
Return on Average Assets (%) (TTM) | 6.2 |
Return on Average Equity (%) (TTM) | 11.9 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}